KOCOSTAR FACE THERAPY ACNE TREATMENT CRE AM TO PAT CH- salicylic acid liquid

KOCOSTAR FACE THERAPY ACNE TREATMENT CRE AM TO PAT CH by

Drug Labeling and Warnings

KOCOSTAR FACE THERAPY ACNE TREATMENT CRE AM TO PAT CH by is a Otc medication manufactured, distributed, or labeled by FIRSTMARKET CO., LTD., Natuzen Co.,Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Salicylic Acid 0.5%

INACTIVE INGREDIENT

Water, Cellulose, Niacinamide, Butylene Glycol, 1,2-Hexanediol, PEG-240/HDI Copolymer Bis-Decyltetradeceth-20 Ether, Caprylic/Capric Triglyceride, Hippophae Rhamnoides Oil, Butylene Glycol Dicaprylate/Dicaprate, Sulfur, Sorbeth-30 Tetraisostearate, Dipropylene Glycol, Sorbitan Sesquiisostearate, Acrylates/Beheneth-25 Methacrylate Copolymer, Tocopherol, Potassium Laurate, PPG-8-Ceteth-20, Capryloyl Salicylic Acid, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Phenoxyethanol, Sodium Lauryl Sulfate, Ethylhexylglycerin, Sodium Benzoate

PURPOSE

Acne treatment

WARNINGS

For external use only.
Do not use on broken skin. large areas of the skin
When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Stop use and ask a doctor if irritation becomes severe.
Avoid contact with eyes. If contact occurs, flush thoroughly with water.

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact Poison Control Center right away.

Uses

for the treatment of acne

clears acne blemishes and allows skin to heal

helps prevent new acne blemishes from forming

Directions

clean the skin thoroughly before applying this productshake welcover the entire affected area with a thin layer using sterile cotton swablet it dry completely and leave in place for 8 hours to permit healingto remove, wet the area with warm water and gently roll with fingertips because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other Information

store at room temperaturekeep away from heat or direct sunlightkeep lids tightly closeddo not dip used cotton swab into essence

Questions or comments

www.kocostar.com / ask@kocostar.com

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

KOCOSTAR FACE THERAPY ACNE TREATMENT CRE AM TO PAT CH 
salicylic acid liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 83888-020
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.5 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
1,2-HEXANEDIOL (UNII: TR046Y3K1G)
NIACINAMIDE (UNII: 25X51I8RD4)
WATER (UNII: 059QF0KO0R)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83888-020-01	20 mL in 1 TUBE; Type 0: Not a Combination Product	04/01/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	04/01/2024

Labeler - FIRSTMARKET CO., LTD. (688288012)

Registrant - FIRSTMARKET CO., LTD. (688288012)

Establishment
Name	Address	ID/FEI	Business Operations
Natuzen Co.,Ltd.		688201272	manufacture(83888-020)